EarningsQ4 2025 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q4 2025 Earnings Report

0 Followers

MX:JAZZN Q4 2025 EPS Results

Actual EPS$122.27

Consensus EPS$120.02

Beat/MissBeat by +$2.25

One Year Ago EPS$121.53

Actual Revenue$22.06B

Expected Revenue$21.46B

Beat/MissBeat by +$602.95M

YoY Revenue Growth+10.09%

QuarterQ4 2025

Date02/24/2026

TimeAfter Close

Conference CallTuesday, February 24, 2026

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	117.61 / -	149.707	―
Aug 03, 2026	2026 (Q2)	113.71 / 105.14	-151.917	169.21% (+257.06)
May 05, 2026	2026 (Q1)	85.46 / 116.75	30.936	277.38% (+85.81)
Feb 24, 2026	2025 (Q4)	120.02 / 122.27	121.534	0.61% (+0.74)
Nov 05, 2025	2025 (Q3)	109.49 / 149.71	121.718	23.00% (+27.99)
Aug 05, 2025	2025 (Q2)	-140.06 / -151.92	97.595	-255.66% (-249.51)
May 06, 2025	2025 (Q1)	85.77 / 30.94	49.35	-37.31% (-18.41)
Feb 25, 2025	2024 (Q4)	107.94 / 121.53	92.439	31.47% (+29.09)
Nov 06, 2024	2024 (Q3)	101.24 / 121.72	89.125	36.57% (+32.59)
Jul 31, 2024	2024 (Q2)	90.63 / 97.60	83.048	17.52% (+14.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed